For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...

A pill that mimics the effect of a gastric bypass has been touted as the latest weight loss miracle - and may even be more ...

A new analysis being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), finds that around half of the 100 top ...

A DAILY weight loss pill is a safer alternative to gastric bypass surgery, makers say. The tablet does the same job by making people feel full for longer. Its developers say the treatment is a ...

Tirzepatide is more effective than semaglutide for weight loss, according to a new study on GLP-1 medications . The study was ...

In May 2024, the “Kelly Clarkson Show” host admitted to using a weight-loss drug to slim down after receiving a prediabetes ...

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on NVO.

The U.S. Food and Drug Administration (FDA) has issued a warning to patients and healthcare professionals regarding the use ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...